2021
DOI: 10.1016/j.bios.2021.113377
|View full text |Cite
|
Sign up to set email alerts
|

Sizes and ligands tuned gold nanocluster acting as a new type of monoamine oxidase B inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 62 publications
0
10
0
Order By: Relevance
“…Recently, AuNCs have been extensively demonstrated as nanoantibiotics for treating bacterial infections because of their unique chemical and physical properties. Significant achievements have been made in the design of AuNCs with different functional ligands such as amino acids, peptides, enzymes, and antibiotics for antibacterial applications. For instance, peptide-conjugated AuNCs loaded with vancomycin showed higher antimicrobial activity compared to vancomycin alone against both Gram-positive Staphylococcus aureus and Gram-negative E. coli .…”
Section: Introductionmentioning
confidence: 99%
“…Recently, AuNCs have been extensively demonstrated as nanoantibiotics for treating bacterial infections because of their unique chemical and physical properties. Significant achievements have been made in the design of AuNCs with different functional ligands such as amino acids, peptides, enzymes, and antibiotics for antibacterial applications. For instance, peptide-conjugated AuNCs loaded with vancomycin showed higher antimicrobial activity compared to vancomycin alone against both Gram-positive Staphylococcus aureus and Gram-negative E. coli .…”
Section: Introductionmentioning
confidence: 99%
“…MAO-B, a metabolic enzyme for accounting for 80% of total MAO in the brain ( Ramsay, 2016 ) while only a little existed in peripheral platelets and lymphocytes ( Naoi et al, 2016 ), is considered to be expressed in neurons and glial cells. MAO-B is associated with neuronal apoptosis, cellular excitotoxicity and oxidative stress in neuropsychiatric diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD) and depression ( Tong et al, 2017 ; Park et al, 2019 ; Wu X. et al, 2021 ). It has been recently reported that ROS produced by MAO-B caused mitochondrial dysfunction and NF-κB activation, leading to NLRP3 inflammasome activation and IL-1β overexpression ( Sanchez-Rodriguez et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…[147] Recently, metal NCs were reported to act as monoamine oxidase B inhibitors (MAOI), which paved the way for creating a more effective drug for Alzheimer's disease. [142] The Au NCs and enzymatic substrates exhibit competitive relationships. When Au NCs bind with MAO active sites like a plug, substrates cannot access the active sites; therefore, no enzymatic reaction can occur.…”
Section: Biocatalystsmentioning
confidence: 99%